North America Veterinary Regenerative Medicine Market Size & Outlook
Related Markets
North America veterinary regenerative medicine market highlights
- The North America veterinary regenerative medicine market generated a revenue of USD 542.2 million in 2025.
- The market is expected to grow at a CAGR of 9.9% from 2026 to 2033.
- In terms of segment, stem cells was the largest revenue generating product in 2025.
- Other Products is the most lucrative product segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2026 to 2033.
North America data book summary
| Market revenue in 2025 | USD 542.2 million |
| Market revenue in 2033 | USD 1,127.2 million |
| Growth rate | 9.9% (CAGR from 2026 to 2033) |
| Largest segment | Stem cells |
| Fastest growing segment | Other Products |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stem cells, Platelet-Rich Plasma (PRP), Other Products |
| Key market players worldwide | Boehringer Ingelheim, Zoetis Inc Class A, Dechra Pharmaceuticals, Integra Lifesciences Holdings Corp, Ardent Health Services, Vetherapy, VET-STEM INC., Enso Discoveries, Animal Cell Therapies |
Other key industry trends
- In terms of revenue, North America region accounted for 37.3% of the global veterinary regenerative medicine market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 755.7 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Veterinary Regenerative Medicine Market Scope
Veterinary Regenerative Medicine Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Animal Cell Therapies | View profile | 1-10 | San Diego, California, United States, North America | http://actcells.com |
| Enso Discoveries | View profile | 1-10 | Manhattan, Kansas, United States, North America | https://www.ensodiscoveries.com |
| VET-STEM INC. | View profile | - | Poway, California, United States, North America | https://vetstem.com/ |
| Vetherapy | View profile | 1-10 | Coimbrã, Leiria, Portugal, Europe | https://www.vetherapy.co/ |
| Ardent Health Services | View profile | 10001+ | Nashville, Tennessee, United States, North America | http://ardenthealth.com |
| Dechra Pharmaceuticals | View profile | 501-1000 | Northwich, Cheshire, United Kingdom, Europe | http://www.dechra.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Integra Lifesciences Holdings Corp | View profile | 3946 | 1100 Campus Road, Princeton, NJ, United States, 08540 | https://www.integralife.com |
| Zoetis Inc Class A | View profile | 14100 | 10 Sylvan Way, Parsippany, NJ, United States, 07054 | https://www.zoetis.com |
North America veterinary regenerative medicine market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to veterinary regenerative medicine market will help companies and investors design strategic landscapes.
Stem cells was the largest segment with a revenue share of 59.66% in 2025. Horizon Databook has segmented the North America veterinary regenerative medicine market based on stem cells, platelet-rich plasma (prp), other products covering the revenue growth of each sub-segment from 2021 to 2033.
The North America veterinary regenerative medicine market held the largest share of 41.53% of the global market in 2023, primarily due to the high prevalence of canine osteoarthritis and the limitations of existing treatment options. Regenerative medicine, featuring stem cell transplants, stands out as a cutting-edge and FDA-approved approach for addressing orthopedic problems in dogs.
It is a highly promising solution for improving the quality of life for pets suffering from arthritis. The rising prevalence of osteoarthritis in dogs, affecting nearly 40% of the canine population in the U.S., poses a significant health concern. This condition is physically painful and takes a toll on the emotional wellbeing of pets.
Existing treatment options for osteoarthritis in dogs have limitations, including low effectiveness, challenges in administration, and safety concerns, resulting in a low treatment rate. Regenerative Medicine, notably using FDA-approved stem cell transplants, emerges as a groundbreaking solution. It promotes joint regeneration and addresses various canine orthopedic issues, including arthritis, tendon and ligament injuries, cartilage damage, and bone fractures.
Reasons to subscribe to North America veterinary regenerative medicine market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America veterinary regenerative medicine market databook
-
Our clientele includes a mix of veterinary regenerative medicine market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America veterinary regenerative medicine market , including forecasts for subscribers. This continent databook contains high-level insights into North America veterinary regenerative medicine market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America veterinary regenerative medicine market size, by country, 2021-2033 (US$M)
North America Veterinary Regenerative Medicine Market Outlook Share, 2025 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
